anti-SARS-CoV-2 Spike ECD antibody [B004] (azide free)
CAT.NO. : ARG43739
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
概述
| 产品描述 | Human Monoclonal antibody recognizesSARS-CoV-2 Spike (ECD) |
|---|---|
| 反应物种 | Virus |
| 应用 | ELISA, Neut, WB |
| 宿主 | Human |
| 克隆 | Monoclonal |
| 克隆号 | B004 |
| 靶点名称 | SARS-CoV-2 Spike (ECD) |
| 抗原物种 | Virus |
| 抗原 | Recombinant fragment of SARS-CoV-2 Spike protein ECD region. |
| 偶联标记 | Un-conjugated |
| 別名 | SARS-CoV-2 (COVID-19, 2019-nCoV) Spike Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein |
应用说明
| 应用建议 |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 应用说明 | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
属性
| 形式 | Liquid |
|---|---|
| 纯化 | Affinity purification with immunogen. |
| 缓冲液 | PBS |
| 存放说明 | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
| 注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
生物信息
| 基因名称 | S |
|---|---|
| 全名 | SARS-CoV-2 Spike (ECD) |
| 背景介绍 | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 Spike Protein derived from 2019-nCoV is composed of S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. |
| 产品亮点 | Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Anti-Rabbit IgG secondary antibodies; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 |
New Products
